Woong S. Byun

Goyang, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Charged molecular glue discovery enabled by targeted degron display.

Charged molecular glue discovery enabled by targeted degron display.

Journal: Nature chemical biology

Published: December 13, 2025

Activating p53Y220C with a mutant-specific small molecule.

Activating p53Y220C with a mutant-specific small molecule.

Journal: Nature communications

Published: December 05, 2025

Development of Degraders and 2-pyridinecarboxyaldehyde (2-PCA) as a recruitment Ligand for FBXO22.

Development of Degraders and 2-pyridinecarboxyaldehyde (2-PCA) as a recruitment Ligand for FBXO22.

Journal: bioRxiv : the preprint server for biology

Published: September 02, 2025

An AKR1C3-activated kinase inhibitor prodrug.

An AKR1C3-activated kinase inhibitor prodrug.

Journal: RSC chemical biology

Published: August 20, 2025

Rational Design of CDK12/13 and BRD4 Molecular Glue Degraders.

Rational Design of CDK12/13 and BRD4 Molecular Glue Degraders.

Journal: Angewandte Chemie (International ed. in English)

Published: April 15, 2025

Development of Potent and Selective CK1α Molecular Glue Degraders.

Development of Potent and Selective CK1α Molecular Glue Degraders.

Journal: Journal of medicinal chemistry

Published: January 28, 2025

Activating p53Y220C with a Mutant-Specific Small Molecule.

Activating p53Y220C with a Mutant-Specific Small Molecule.

Journal: bioRxiv : the preprint server for biology

Published: November 18, 2024

Antitumor activity of selenopsammaplin A analog (SPA-10091-HCl) via histone methyltransferase DOT1L degradation and apoptosis induction in castration-resistant prostate cancer cells.

Antitumor activity of selenopsammaplin A analog (SPA-10091-HCl) via histone methyltransferase DOT1L degradation and apoptosis induction in castration-resistant prostate cancer cells.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: November 01, 2024

Discovery of electrophilic degraders that exploit SNAr chemistry.

Discovery of electrophilic degraders that exploit SNAr chemistry.

Journal: bioRxiv : the preprint server for biology

Published: October 10, 2024

Evo312: An Evodiamine Analog and Novel PKCβI Inhibitor with Potent Antitumor Activity in Gemcitabine-Resistant Pancreatic Cancer.

Evo312: An Evodiamine Analog and Novel PKCβI Inhibitor with Potent Antitumor Activity in Gemcitabine-Resistant Pancreatic Cancer.

Journal: Journal of medicinal chemistry

Published: August 16, 2024

Exploration of the tunability of BRD4 degradation by DCAF16 trans-labelling covalent glues.

Exploration of the tunability of BRD4 degradation by DCAF16 trans-labelling covalent glues.

Journal: European journal of medicinal chemistry

Published: July 24, 2024

Discovery of bivalent small molecule degraders of cyclin-dependent kinase 7 (CDK7).

Discovery of bivalent small molecule degraders of cyclin-dependent kinase 7 (CDK7).

Journal: European journal of medicinal chemistry

Published: May 31, 2024

Showing 1-12 of 48

Last Updated: 09/26/2026